| Literature DB >> 15623853 |
David McCoy1, Mickey Chopra, Rene Loewenson, Jean-Marion Aitken, Thabale Ngulube, Adamson Muula, Sunanda Ray, Tendayi Kureyi, Petrida Ijumba, Mike Rowson.
Abstract
We describe a number of pitfalls that may occur with the push to rapidly expand access to antiretroviral therapy in sub-Saharan Africa. These include undesirable opportunity costs, the fragmentation of health systems, worsening health care inequities, and poor and unsustained treatment outcomes. On the other hand, AIDS "treatment activism" provides an opportunity to catalyze comprehensive health systems development and reduce health care inequities.However, these positive benefits will only happen if we explicitly set out to achieve them. We call for a greater commitment toward health activism that tackles the broader political and economic constraints to human and health systems development in Africa, as well as toward the resuscitation of inclusive and equitable public health systems.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15623853 PMCID: PMC1449845 DOI: 10.2105/AJPH.2004.040121
Source DB: PubMed Journal: Am J Public Health ISSN: 0090-0036 Impact factor: 9.308